Works matching AU Weber, Jeffrey

Results: 108
    1
    2
    3
    4
    5

    Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma.

    Published in:
    Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae289
    By:
    • Weber, Jeffrey;
    • Haque, Waqas;
    • Markovic, Svetomir N;
    • Salama, April K S;
    • Mehmi, Inderjit;
    • Sullivan, Ryan J;
    • Najjar, Yana G;
    • Akkooi, Alexander C J van;
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Taylor, Amelia M;
    • Haanen, John;
    • Zijlker, Lisanne P;
    • Davis, Keith L;
    • Karanth, Siddharth;
    • Norton, Deborah;
    • Connolly, Lucy
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Introduction.

    Published in:
    Oncologist, 2008, v. 13, n. 4, p. 1, doi. 10.1634/theoncologist.13-S4-1
    By:
    • Weber, Jeffrey
    Publication type:
    Article
    12

    Introduction.

    Published in:
    Oncologist, 2008, p. 1, doi. 10.1634/theoncologist.13-S4-1
    By:
    • Weber, Jeffrey
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?

    Published in:
    Journal of Neuro-Oncology, 2022, v. 158, n. 3, p. 471, doi. 10.1007/s11060-022-04036-1
    By:
    • Berger, Assaf;
    • Bernstein, Kenneth;
    • Alzate, Juan Diego;
    • Mullen, Reed;
    • Silverman, Joshua S.;
    • Sulman, Erik P.;
    • Donahue, Bernadine R.;
    • Pavlick, Anna C.;
    • Gurewitz, Jason;
    • Mureb, Monica;
    • Mehnert, Janice;
    • Madden, Kathleen;
    • Palermo, Amy;
    • Weber, Jeffrey S.;
    • Golfinos, John G.;
    • Kondziolka, Douglas
    Publication type:
    Article
    22
    23

    Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.

    Published in:
    OncoImmunology, 2023, v. 12, n. 1, p. 1, doi. 10.1080/2162402X.2023.2261264
    By:
    • Reid, Pankti;
    • Sandigursky, Sabina;
    • Song, Juhee;
    • Lopez-Olivo, Maria A.;
    • Safa, Houssein;
    • Cytryn, Samuel;
    • Efuni, Elizaveta;
    • Buni, Maryam;
    • Pavlick, Anna;
    • Krogsgaard, Michelle;
    • Abu-Shawer, Osama;
    • Altan, Mehmet;
    • Weber, Jeffrey S.;
    • Rahma, Osama E.;
    • Suarez-Almazor, Maria E.;
    • Diab, Adi;
    • Abdel-Wahab, Noha
    Publication type:
    Article
    24

    Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38573-8
    By:
    • Li, Xiaolong;
    • Singh, Nishant Kumar;
    • Collins, David R.;
    • Ng, Robert;
    • Zhang, Angela;
    • Lamothe-Molina, Pedro A.;
    • Shahinian, Peter;
    • Xu, Shutong;
    • Tan, Kemin;
    • Piechocka-Trocha, Alicja;
    • Urbach, Jonathan M.;
    • Weber, Jeffrey K.;
    • Gaiha, Gaurav D.;
    • Takou Mbah, Overbeck Christian;
    • Huynh, Tien;
    • Cheever, Sophia;
    • Chen, James;
    • Birnbaum, Michael;
    • Zhou, Ruhong;
    • Walker, Bruce D.
    Publication type:
    Article
    25

    Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapy.

    Published in:
    Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33597-y
    By:
    • Isser, Ariel;
    • Silver, Aliyah B.;
    • Pruitt, Hawley C.;
    • Mass, Michal;
    • Elias, Emma H.;
    • Aihara, Gohta;
    • Kang, Si-Sim;
    • Bachmann, Niklas;
    • Chen, Ying-Yu;
    • Leonard, Elissa K.;
    • Bieler, Joan G.;
    • Chaisawangwong, Worarat;
    • Choy, Joseph;
    • Shannon, Sydney R.;
    • Gerecht, Sharon;
    • Weber, Jeffrey S.;
    • Spangler, Jamie B.;
    • Schneck, Jonathan P.
    Publication type:
    Article
    26

    MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aar3342
    By:
    • Rodig, Scott J.;
    • Gusenleitner, Daniel;
    • Jackson, Donald G.;
    • Gjini, Evisa;
    • Giobbie-Hurder, Anita;
    • Jin, Chelsea;
    • Chang, Han;
    • Lovitch, Scott B.;
    • Horak, Christine;
    • Weber, Jeffrey S.;
    • Weirather, Jason L.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pavlick, Anna C.;
    • Chesney, Jason;
    • Hodi, F. Stephen
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy).

    Published in:
    Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04325-x
    By:
    • Ascierto, Paolo A.;
    • Agarwala, Sanjiv S.;
    • Warner, Allison Betof;
    • Ernstoff, Marc S.;
    • Fox, Bernard A.;
    • Gajewski, Thomas F.;
    • Galon, Jérôme;
    • Garbe, Claus;
    • Gastman, Brian R.;
    • Gershenwald, Jeffrey E.;
    • Kalinski, Pawel;
    • Krogsgaard, Michelle;
    • Leidner, Rom S.;
    • Lo, Roger S.;
    • Menzies, Alexander M.;
    • Michielin, Olivier;
    • Poulikakos, Poulikos I.;
    • Weber, Jeffrey S.;
    • Caracò, Corrado;
    • Osman, Iman
    Publication type:
    Article
    36
    37
    38

    Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03697-3
    By:
    • Moser, Justin C.;
    • Bhatia, Shailender;
    • Amin, Asim;
    • Pavlick, Anna C.;
    • Betts, Keith A.;
    • Du, Ella Xiaoyan;
    • Poretta, Tayla;
    • Shelley, Karishma;
    • Srinivasan, Swetha;
    • Sakkal, Leon Alan;
    • Palaia, Jennell;
    • Lobo, Maurice;
    • Pe Benito, Melanie;
    • Linton, Joshua A.;
    • Chen, Yan;
    • Xu, Churong;
    • Yin, Lei;
    • Sundar, Manasvi;
    • Weber, Jeffrey
    Publication type:
    Article
    39
    40

    Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 945, doi. 10.1007/s00262-022-03302-5
    By:
    • Weber, Jeffrey S.;
    • Poretta, Tayla;
    • Stwalley, Brian D.;
    • Sakkal, Leon A.;
    • Du, Ella X.;
    • Wang, Travis;
    • Chen, Yan;
    • Wang, Yan;
    • Betts, Keith A.;
    • Shoushtari, Alexander N.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50